Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Larry H. Danziger"'
Publikováno v:
Antibiotics, Vol 4, Iss 2, Pp 198-215 (2015)
Clostridium difficile remains a major public health threat and continues to contribute to excess morbidity, mortality and healthcare costs. Antimicrobial stewardship programs have demonstrated success in combating C. difficile, primarily through anti
Externí odkaz:
https://doaj.org/article/f0e5ea0e8e93423bae905acb47802db9
Publikováno v:
International Journal of Infectious Diseases, Vol 30, Iss C, Pp 125-132 (2015)
Objective: To review recent clinical pharmacokinetic and pharmacodynamic data to optimize dosing regimens for polymyxin B and colistin for treatment of infections due to A. baumannii. Methods: A literature search was performed using the search terms
Externí odkaz:
https://doaj.org/article/7df08b94486942c9a26bcf9070083c2f
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 7 (2013)
Non-cystic fibrosis bronchiectasis (NCFBE), a historically under-recognized chronic respiratory condition, is a significant diagnosis currently experiencing a resurgence of interest in its clinical management. Ciprofloxacin is part of the current arm
Externí odkaz:
https://doaj.org/article/a1c621967dd74a8a849984e3632ac4ba
Publikováno v:
Journal of Pharmacy Practice. :089719002311679
Mosquito-borne diseases are a public health concern. Pharmacists are often a patient’s first stop for health information and may be asked questions regarding transmission, symptoms, and treatment of mosquito borne viruses (MBVs). The objective of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91a3f7fe37451085ff0eee0cd3f5cd2c
https://doi.org/10.1177/08971900231167929
https://doi.org/10.1177/08971900231167929
Autor:
Benjamin D Sirbu, Stuart Johnson, Larry H. Danziger, Xing Tan, Andrew M Skinner, Dale N. Gerding
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 73(6)
We treated 46 patients with multiple recurrent Clostridioides difficile infections (mrCDI) using a tapered-pulsed (T-P) fidaxomicin regimen, the majority of whom failed prior T-P vancomycin treatment. Sustained clinical response rates at 30 and 90 da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20983770385070032ec18bc33c21bc01
https://pubmed.ncbi.nlm.nih.gov/33714998
https://pubmed.ncbi.nlm.nih.gov/33714998
Autor:
Nicole C. Griffith, Larry H. Danziger
Publikováno v:
Antibiotics, Vol 9, Iss 898, p 898 (2020)
Antibiotics
Antibiotics
Candida auris is a globally emerging pathogen that has been identified in urinary tract infections (UTIs) worldwide. The novel pathogen is characterized by common misidentification, difficult eradication, and multidrug resistance. To date, there is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0afc6fb05a3fabdcd318d2e83368fa6d
https://www.mdpi.com/2079-6382/9/12/898
https://www.mdpi.com/2079-6382/9/12/898
Autor:
Eric Wenzler, Maressa Santarossa, Alyssa Christensen, Amy Hanson, Amanda T. Harrington, Lisa R Young, Mark Biagi, Vikas Gupta, David A Butler, Tim Murrey, Mike Postelnick, Sarah M. Wieczorkiewicz, Julie Giddens, Natasha Pettit, Ursula C. Patel, Larry H. Danziger, Sharon Sam, Sandy Naegele, Mira Suseno
Publikováno v:
Infection control and hospital epidemiology. 41(12)
Objective:To develop a regional antibiogram within the Chicagoland metropolitan area and to compare regional susceptibilities against individual hospitals within the area and national surveillance data.Design:Multicenter retrospective analysis of ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30af19353326dc36308c2dd77107f0b
https://pubmed.ncbi.nlm.nih.gov/32886058
https://pubmed.ncbi.nlm.nih.gov/32886058
Autor:
Matthew Finnemeyer, Susan L. Rosenkranz, Susan C Bleasdale, Eric Wenzler, K M Meyer, Larry H. Danziger, Kristen L. Bunnell, Keith A. Rodvold, R E Mendes, Monica K. Sikka
Publikováno v:
Antimicrob Agents Chemother
The ex vivo bactericidal activity and pharmacodynamics of fosfomycin in urine were evaluated in 18 healthy subjects. Subjects received 3 g every other day (QOD) for 3 doses and then every day (QD) for 7 doses or vice versa. Serial urine samples were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9006c6c72048f8e584f34236acd6cd5
https://doi.org/10.1128/aac.02102-19
https://doi.org/10.1128/aac.02102-19
Pharmacokinetic evaluation of meropenem and vaborbactam for the treatment of urinary tract infection
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 14:1007-1021
Meropenem/vaborbactam (M/V) represents the first carbapenem and β-lactamase inhibitor combination approved for treatment of complicated urinary tract infections (cUTIs), including pyelonephritis. Vaborbactam is a novel boronic acid, β-lactamase inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e4d3e93738eee1cab3520598e948660
https://doi.org/10.1080/17425255.2018.1511702
https://doi.org/10.1080/17425255.2018.1511702
Publikováno v:
International Journal of Antimicrobial Agents. 51:700-706
Background There is a need to identify practice patterns of polymyxin use, quantify gaps in knowledge, and recognize areas of persistent confusion. Methods A structured electronic survey was distributed to physicians, pharmacists and microbiologists.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a185e2ae72e9a629389df0389b753506
https://doi.org/10.1016/j.ijantimicag.2017.12.023
https://doi.org/10.1016/j.ijantimicag.2017.12.023